OmegaGenesis is a bio-technology company developing nano-materials for human body management to effectively treat conditions where the growth or anti-growth of blood cells determines the outcome.
Human body management applications where blood vessels greatly determine the outcome range from cancer and malignancies treatments to common wound healing and skin reactivation.
OmegaGenesis was founded to discover and produce suitable nano-materials to manage human body functions at nano scale – the cell and sub-cell level -- accelerating cellular-based biologic therapies. These nano-materials will enable Doctors to treat disease at sub-cell level in a less intrusive manner instead of treating the disease at the organ or tissue level.
Human body management applications where blood vessels greatly determine the outcome range from cancer and malignancies treatments to common wound healing and skin reactivation.
OmegaGenesis was founded to discover and produce suitable nano-materials to manage human body functions at nano scale – the cell and sub-cell level -- accelerating cellular-based biologic therapies. These nano-materials will enable Doctors to treat disease at sub-cell level in a less intrusive manner instead of treating the disease at the organ or tissue level.
Innovation in Science and New
Materials
The advances in the area of the human genomic, molecular medicine and tremendous progress in nanotechnology provides an opportunity to understand disease at molecular level and provide applications to treat at the nano level.
It is now possible to look inside a cell to stimulate the organic growth of blood cells in constructive conditions or inhibit the expansion of blood cells to stop destructive growth.
Angiogenesis is the formation of new blood vessels from pre-existing vessels. Angiogenesis is a normal process in growth and development, as well as, in wound healing. However, this is also a fundamental step in the transition of tumors from a dormant state to a malignant state.
The process of angiogenesis is controlled by certain chemicals produced in the body. Some of these chemicals stimulate cells to repair damaged blood vessels or form new ones. Other chemicals, called angiogenesis inhibitors, signal the process to stop.
Angiogenesis plays an important role in the growth and spread of cancer and malignancies. New blood vessels "feed" the cancer cells with oxygen and nutrients, allowing these cells to grow, invade nearby tissue, spread to other parts of the body, and form new colonies of cancer cells.
Therapeutic angiogenesis is the application of specific compounds or nano-materials which may inhibit or induce the creation of new blood vessels in the body in order to combat disease. OmegaGenesis is utilizing advance nanotechnologies in molecular medicine to produce suitable nano materials to manage angiogenesis process at nano-scale. The size of the nano particles is about 1/100th of a white blood cell and this allows nano operations at sub-cell levels.
The Company is developing suitable nano-materials to manage human body functions at nano scale – the cell and sub-cell level -- accelerating cellular-based biologic therapies where the growth of blood vessels determines the outcome. The Company’s goal is to supplement the natural human angiogenesis process and re-enable where some natural processes have stopped or diminished. This approach provides for early and pre-disease intervention in most cases.
It is now possible to look inside a cell to stimulate the organic growth of blood cells in constructive conditions or inhibit the expansion of blood cells to stop destructive growth.
Angiogenesis is the formation of new blood vessels from pre-existing vessels. Angiogenesis is a normal process in growth and development, as well as, in wound healing. However, this is also a fundamental step in the transition of tumors from a dormant state to a malignant state.
The process of angiogenesis is controlled by certain chemicals produced in the body. Some of these chemicals stimulate cells to repair damaged blood vessels or form new ones. Other chemicals, called angiogenesis inhibitors, signal the process to stop.
Angiogenesis plays an important role in the growth and spread of cancer and malignancies. New blood vessels "feed" the cancer cells with oxygen and nutrients, allowing these cells to grow, invade nearby tissue, spread to other parts of the body, and form new colonies of cancer cells.
Therapeutic angiogenesis is the application of specific compounds or nano-materials which may inhibit or induce the creation of new blood vessels in the body in order to combat disease. OmegaGenesis is utilizing advance nanotechnologies in molecular medicine to produce suitable nano materials to manage angiogenesis process at nano-scale. The size of the nano particles is about 1/100th of a white blood cell and this allows nano operations at sub-cell levels.
The Company is developing suitable nano-materials to manage human body functions at nano scale – the cell and sub-cell level -- accelerating cellular-based biologic therapies where the growth of blood vessels determines the outcome. The Company’s goal is to supplement the natural human angiogenesis process and re-enable where some natural processes have stopped or diminished. This approach provides for early and pre-disease intervention in most cases.